Single Source · The Motley Fool

This is one outlet's own report from The Motley Fool — the article as it was filed.

AIPROPX ReportThe Motley Fool · 2h ago

Wall Street Isn't Giving Up on CVS Health -- and Its Valuation Looks Stronger Than Investors Think

CVS Health (NYSE: CVS) is a vertically integrated healthcare giant. It has around 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics, and is a leading pharmacy benefits manager with approximately 87 million plan members. Its Aetna segment is No. 2 in health insurance market share, according to the most recent National Association of Insurance Commissioners figures.

The company reported second-quarter earnings on Aug. 5. Revenue was $106.1 billion, up 7.3% year over year. Earnings per share (EPS) were up 188% over the same period, to $2.31.

CVS is predicting revenue of at least $414 billion in 2026, up from earlier estimates of at least $405 billion. Yearly EPS was forecasted between $6.84 and $7.04, again an increase from the earlier guidance of $6.24 to $6.44.

Read it at the originRead the full report at The Motley Fool

◆ AIPROPX index record

Region: Other
Detected names: CVS HealthNYSECVSIts AetnaNational AssociationInsurance CommissionersAugRevenueEarningsEPSYearly EPSContinue

AIPROPX is an independent multi-source news index — we track, compare, and connect coverage from across the web into one place you won't find anywhere else.